 | • レポートコード：QYR9N7423 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、腎臓がんのグローバル市場について調査・分析したレポートで、種類別（腎細胞がん（RCC）、移行上皮がん（TCC））、用途別（手術、免疫療法、化学療法、放射線療法）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・腎臓がんの世界市場規模 ・主要企業別市場シェア ・腎臓がんの世界市場規模：種類別（腎細胞がん（RCC）、移行上皮がん（TCC）） ・腎臓がんの世界市場規模：用途別（手術、免疫療法、化学療法、放射線療法） ・腎臓がんのアメリカ市場規模（種類別、用途別） ・腎臓がんのヨーロッパ市場規模（種類別、用途別） ・腎臓がんの中国市場規模（種類別、用途別） ・腎臓がんの日本市場規模（種類別、用途別） ・腎臓がんの東南アジア市場規模（種類別、用途別） ・腎臓がんのインド市場規模（種類別、用途別） ・腎臓がんの中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・腎臓がんの世界市場予測（2019年-2025年） ・腎臓がんの地域別市場予測（2019年-2025年） ... |
Kidney cancer is a type of cancer that starts in the cells in the kidney.The growth of the market is attributed to increasing incidence of kidney cancers and increasing ill lifestyle changes which gets worsen with addiction of tobacco and alcohol. Furthermore, overexposure to radiation during treatment testicular cancer, growing awareness program, and increasing mortality due to kidney cancer are boosting the kidney cancer market.
In 2018, the global Kidney Cancer market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Kidney Cancer status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Kidney Cancer development in United States, Europe and China.
The key players covered in this study
Merck
Novartis
AstraZeneca
Bristol-Myers Squibb
Pfizer
Roche
Amgen
Argos Therapeutics
Aveo Pharmaceuticals
Bayer
Exelixis
Incyte
Allergan
Market segment by Type, the product can be split into
Renal Cell Carcinoma (RCC)
Transitional Cell Carcinoma (TCC)
Market segment by Application, split into
Surgery
Immunotherapy
Chemotherapy
Radiation Therapy
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Kidney Cancer status, future forecast, growth opportunity, key market and key players.
To present the Kidney Cancer development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Kidney Cancer are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Kidney Cancer Market Size Growth Rate by Type (2014-2025)
1.4.2 Renal Cell Carcinoma (RCC)
1.4.3 Transitional Cell Carcinoma (TCC)
1.5 Market by Application
1.5.1 Global Kidney Cancer Market Share by Application (2014-2025)
1.5.2 Surgery
1.5.3 Immunotherapy
1.5.4 Chemotherapy
1.5.5 Radiation Therapy
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Kidney Cancer Market Size
2.2 Kidney Cancer Growth Trends by Regions
2.2.1 Kidney Cancer Market Size by Regions (2014-2025)
2.2.2 Kidney Cancer Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Kidney Cancer Market Size by Manufacturers
3.1.1 Global Kidney Cancer Revenue by Manufacturers (2014-2019)
3.1.2 Global Kidney Cancer Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Kidney Cancer Market Concentration Ratio (CR5 and HHI)
3.2 Kidney Cancer Key Players Head office and Area Served
3.3 Key Players Kidney Cancer Product/Solution/Service
3.4 Date of Enter into Kidney Cancer Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Kidney Cancer Market Size by Type (2014-2019)
4.2 Global Kidney Cancer Market Size by Application (2014-2019)
5 United States
5.1 United States Kidney Cancer Market Size (2014-2019)
5.2 Kidney Cancer Key Players in United States
5.3 United States Kidney Cancer Market Size by Type
5.4 United States Kidney Cancer Market Size by Application
6 Europe
6.1 Europe Kidney Cancer Market Size (2014-2019)
6.2 Kidney Cancer Key Players in Europe
6.3 Europe Kidney Cancer Market Size by Type
6.4 Europe Kidney Cancer Market Size by Application
7 China
7.1 China Kidney Cancer Market Size (2014-2019)
7.2 Kidney Cancer Key Players in China
7.3 China Kidney Cancer Market Size by Type
7.4 China Kidney Cancer Market Size by Application
8 Japan
8.1 Japan Kidney Cancer Market Size (2014-2019)
8.2 Kidney Cancer Key Players in Japan
8.3 Japan Kidney Cancer Market Size by Type
8.4 Japan Kidney Cancer Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Kidney Cancer Market Size (2014-2019)
9.2 Kidney Cancer Key Players in Southeast Asia
9.3 Southeast Asia Kidney Cancer Market Size by Type
9.4 Southeast Asia Kidney Cancer Market Size by Application
10 India
10.1 India Kidney Cancer Market Size (2014-2019)
10.2 Kidney Cancer Key Players in India
10.3 India Kidney Cancer Market Size by Type
10.4 India Kidney Cancer Market Size by Application
11 Central & South America
11.1 Central & South America Kidney Cancer Market Size (2014-2019)
11.2 Kidney Cancer Key Players in Central & South America
11.3 Central & South America Kidney Cancer Market Size by Type
11.4 Central & South America Kidney Cancer Market Size by Application
12 International Players Profiles
12.1 Merck
12.1.1 Merck Company Details
12.1.2 Company Description and Business Overview
12.1.3 Kidney Cancer Introduction
12.1.4 Merck Revenue in Kidney Cancer Business (2014-2019)
12.1.5 Merck Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Company Description and Business Overview
12.2.3 Kidney Cancer Introduction
12.2.4 Novartis Revenue in Kidney Cancer Business (2014-2019)
12.2.5 Novartis Recent Development
12.3 AstraZeneca
12.3.1 AstraZeneca Company Details
12.3.2 Company Description and Business Overview
12.3.3 Kidney Cancer Introduction
12.3.4 AstraZeneca Revenue in Kidney Cancer Business (2014-2019)
12.3.5 AstraZeneca Recent Development
12.4 Bristol-Myers Squibb
12.4.1 Bristol-Myers Squibb Company Details
12.4.2 Company Description and Business Overview
12.4.3 Kidney Cancer Introduction
12.4.4 Bristol-Myers Squibb Revenue in Kidney Cancer Business (2014-2019)
12.4.5 Bristol-Myers Squibb Recent Development
12.5 Pfizer
12.5.1 Pfizer Company Details
12.5.2 Company Description and Business Overview
12.5.3 Kidney Cancer Introduction
12.5.4 Pfizer Revenue in Kidney Cancer Business (2014-2019)
12.5.5 Pfizer Recent Development
12.6 Roche
12.6.1 Roche Company Details
12.6.2 Company Description and Business Overview
12.6.3 Kidney Cancer Introduction
12.6.4 Roche Revenue in Kidney Cancer Business (2014-2019)
12.6.5 Roche Recent Development
12.7 Amgen
12.7.1 Amgen Company Details
12.7.2 Company Description and Business Overview
12.7.3 Kidney Cancer Introduction
12.7.4 Amgen Revenue in Kidney Cancer Business (2014-2019)
12.7.5 Amgen Recent Development
12.8 Argos Therapeutics
12.8.1 Argos Therapeutics Company Details
12.8.2 Company Description and Business Overview
12.8.3 Kidney Cancer Introduction
12.8.4 Argos Therapeutics Revenue in Kidney Cancer Business (2014-2019)
12.8.5 Argos Therapeutics Recent Development
12.9 Aveo Pharmaceuticals
12.9.1 Aveo Pharmaceuticals Company Details
12.9.2 Company Description and Business Overview
12.9.3 Kidney Cancer Introduction
12.9.4 Aveo Pharmaceuticals Revenue in Kidney Cancer Business (2014-2019)
12.9.5 Aveo Pharmaceuticals Recent Development
12.10 Bayer
12.10.1 Bayer Company Details
12.10.2 Company Description and Business Overview
12.10.3 Kidney Cancer Introduction
12.10.4 Bayer Revenue in Kidney Cancer Business (2014-2019)
12.10.5 Bayer Recent Development
12.11 Exelixis
12.12 Incyte
12.13 Allergan
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Kidney Cancer Key Market Segments
Table Key Players Kidney Cancer Covered
Table Global Kidney Cancer Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Kidney Cancer Market Size Market Share by Type 2014-2025
Figure Renal Cell Carcinoma (RCC) Figures
Table Key Players of Renal Cell Carcinoma (RCC)
Figure Transitional Cell Carcinoma (TCC) Figures
Table Key Players of Transitional Cell Carcinoma (TCC)
Table Global Kidney Cancer Market Size Growth by Application 2014-2025 (Million US$)
Figure Surgery Case Studies
Figure Immunotherapy Case Studies
Figure Chemotherapy Case Studies
Figure Radiation Therapy Case Studies
Figure Kidney Cancer Report Years Considered
Table Global Kidney Cancer Market Size 2014-2025 (Million US$)
Figure Global Kidney Cancer Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Kidney Cancer Market Size by Regions 2014-2025 (Million US$)
Table Global Kidney Cancer Market Size by Regions 2014-2019 (Million US$)
Table Global Kidney Cancer Market Share by Regions 2014-2019
Figure Global Kidney Cancer Market Share by Regions 2014-2019
Figure Global Kidney Cancer Market Share by Regions 2019
Table Market Top Trends
Table Global Kidney Cancer Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Kidney Cancer Market Share by Manufacturers (2014-2019)
Figure Global Kidney Cancer Market Share by Manufacturers in 2018
Table Global Kidney Cancer Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Kidney Cancer Product/Solution/Service
Table Date of Enter into Kidney Cancer Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Kidney Cancer Market Size by Type (2014-2019) (Million US$)
Table Global Kidney Cancer Market Size Share by Type (2014-2019)
Figure Global Kidney Cancer Market Size Market Share by Type (2014-2019)
Table Global Kidney Cancer Market Size by Application (2014-2019) (Million US$)
Table Global Kidney Cancer Market Size Share by Application (2014-2019)
Figure Global Kidney Cancer Market Size Market Share by Application (2014-2019)
Figure Global Kidney Cancer Revenue Market Share by Application in 2018
Figure United States Kidney Cancer Market Size 2014-2019 (Million US$)
Table United States Key Players Kidney Cancer Revenue (2018-2019) (Million US$)
Table United States Key Players Kidney Cancer Market Share (2018-2019)
Table United States Kidney Cancer Market Size by Type (2014-2019) (Million US$)
Table United States Kidney Cancer Market Share by Type (2014-2019)
Table United States Kidney Cancer Market Size by Application (2014-2019) (Million US$)
Table United States Kidney Cancer Market Share by Application (2014-2019)
Figure Europe Kidney Cancer Market Size 2014-2019 (Million US$)
Table Europe Key Players Kidney Cancer Revenue (2018-2019) (Million US$)
Table Europe Key Players Kidney Cancer Market Share (2018-2019)
Table Europe Kidney Cancer Market Size by Type (2014-2019) (Million US$)
Table Europe Kidney Cancer Market Share by Type (2014-2019)
Table Europe Kidney Cancer Market Size by Application (2014-2019) (Million US$)
Table Europe Kidney Cancer Market Share by Application (2014-2019)
Figure China Kidney Cancer Market Size 2014-2019 (Million US$)
Table China Key Players Kidney Cancer Revenue (2018-2019) (Million US$)
Table China Key Players Kidney Cancer Market Share (2018-2019)
Table China Kidney Cancer Market Size by Type (2014-20189) (Million US$)
Table China Kidney Cancer Market Share by Type (2014-2019)
Table China Kidney Cancer Market Size by Application (2014-2019) (Million US$)
Table China Kidney Cancer Market Share by Application (2014-2019)
Figure Japan Kidney Cancer Market Size 2014-2019 (Million US$)
Table Japan Key Players Kidney Cancer Revenue (2018-2019) (Million US$)
Table Japan Key Players Kidney Cancer Market Share (2018-2019)
Table Japan Kidney Cancer Market Size by Type (2014-2019) (Million US$)
Table Japan Kidney Cancer Market Share by Type (2014-2019)
Table Japan Kidney Cancer Market Size by Application (2014-2019) (Million US$)
Table Japan Kidney Cancer Market Share by Application (2014-2019)
Figure Southeast Asia Kidney Cancer Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Kidney Cancer Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Kidney Cancer Market Share (2018-2019)
Table Southeast Asia Kidney Cancer Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Kidney Cancer Market Share by Type (2014-2019)
Table Southeast Asia Kidney Cancer Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Kidney Cancer Market Share by Application (2014-2019)
Figure India Kidney Cancer Market Size 2014-2019 (Million US$)
Table India Key Players Kidney Cancer Revenue (2018-2019) (Million US$)
Table India Key Players Kidney Cancer Market Share (2018-2019)
Table India Kidney Cancer Market Size by Type (2014-2019) (Million US$)
Table India Kidney Cancer Market Share by Type (2014-2019)
Table India Kidney Cancer Market Size by Application (2014-2019) (Million US$)
Table India Kidney Cancer Market Share by Application (2014-2019)
Figure Central & South America Kidney Cancer Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Kidney Cancer Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Kidney Cancer Market Share (2018-2019)
Table Central & South America Kidney Cancer Market Size by Type (2014-2019) (Million US$)
Table Central & South America Kidney Cancer Market Share by Type (2014-2019)
Table Central & South America Kidney Cancer Market Size by Application (2014-2019) (Million US$)
Table Central & South America Kidney Cancer Market Share by Application (2014-2019)
Table Merck Company Details
Table Merck Revenue in Kidney Cancer Business (2014-2019) (Million US$)
Figure Merck Revenue Growth Rate in Kidney Cancer Business (2014-2019)
Table Merck Recent Development
Table Novartis Company Details
Table Novartis Revenue in Kidney Cancer Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Kidney Cancer Business (2014-2019)
Table Novartis Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Kidney Cancer Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Kidney Cancer Business (2014-2019)
Table AstraZeneca Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Kidney Cancer Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Kidney Cancer Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Kidney Cancer Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Kidney Cancer Business (2014-2019)
Table Pfizer Recent Development
Table Roche Company Details
Table Roche Revenue in Kidney Cancer Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Kidney Cancer Business (2014-2019)
Table Roche Recent Development
Table Amgen Company Details
Table Amgen Revenue in Kidney Cancer Business (2014-2019)(Million US$)
Figure Amgen Revenue Growth Rate in Kidney Cancer Business (2014-2019)
Table Amgen Recent Development
Table Argos Therapeutics Company Details
Table Argos Therapeutics Revenue in Kidney Cancer Business (2014-2019)(Million US$)
Figure Argos Therapeutics Revenue Growth Rate in Kidney Cancer Business (2014-2019)
Table Argos Therapeutics Recent Development
Table Aveo Pharmaceuticals Company Details
Table Aveo Pharmaceuticals Revenue in Kidney Cancer Business (2014-2019)(Million US$)
Figure Aveo Pharmaceuticals Revenue Growth Rate in Kidney Cancer Business (2014-2019)
Table Aveo Pharmaceuticals Recent Development
Table Bayer Company Details
Table Bayer Revenue in Kidney Cancer Business (2014-2019)(Million US$)
Figure Bayer Revenue Growth Rate in Kidney Cancer Business (2014-2019)
Table Bayer Recent Development
Table Exelixis Company Details
Table Incyte Company Details
Table Allergan Company Details
Table Global Kidney Cancer Market Size by Regions (Million US$) 2019-2025
Figure Global Kidney Cancer Market Size Share by Regions (2019-2025)
Figure Global Kidney Cancer Market Size Share by Regions in 2025
Figure United States Kidney Cancer Market Size Forecast (2019-2025)(Million USD)
Figure Europe Kidney Cancer Market Size Forecast (2019-2025)(Million USD)
Figure China Kidney Cancer Market Size Forecast (2019-2025)(Million USD)
Figure Japan Kidney Cancer Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Kidney Cancer Market Size Forecast (2019-2025)(Million USD)
Figure India Kidney Cancer Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Kidney Cancer Market Size Forecast (2019-2025)(Million USD)
Table Global Kidney Cancer Market Size by Product (2019-2025) (Million US$)
Figure Global Kidney Cancer Market Size by Product (2019-2025)
Figure Global Kidney Cancer Market Size by Product in 2025
Table Global Kidney Cancer Market Size by Application (2019-2025) (Million US$)
Figure Global Kidney Cancer Market Size by Application (2019-2025)
Figure Global Kidney Cancer Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の移行上皮がん治療薬市場：市場規模・現状・予測 Transitional cell carcinoma (TCC) occur in the different parts of urinary tract, which include kidney, bladder, or urethra.Market revenue drivers for the transitional cell cancer therapeutics market include increase in environmental pollution levels coupled with high rates of cigarette smoking. In 2…- 世界の頭頸部治療の扁平上皮がん市場：市場規模・現状・予測 Head and neck cancer usually occurs in the squamous cells present inside the mouth, nose and throat. These squamous cells are usually known as squamous cell carcinoma of the head and neck.In 2018, the global Squamous Cell Carcinoma of the Head and Neck Treatment market size was xx million US$ and it…
- 世界の樹状細胞がんワクチン市場：市場規模・現状・予測 Dendritic cells (DCs) refer to rare kind of leukocytes. They have prompted their recent application to therapeutic cancer vaccinations as they are uniquely effective in their ability to present antigens to T cells. Isolated DCs loaded with tumor antigen ex vivo and administered as a cellular vaccine…
- 世界の尿路上皮がんの治療市場：市場規模・現状・予測 Urothelial carcinoma is also called as transitional cell carcinoma which is a cancerous tumor of the bladder that can spread to other parts of the body. These are also called as malignant tumors. This tumor can start at any part of the urinary tract. People with bladder cancer may also have similar …
- 世界の皮膚がんの診断と治療市場：市場規模・現状・予測 Skin cancer is the uncontrolled development of anomalous skin cells.The major factor that drives the market is that when the sun rays that is the ultra violet rays comes in contact with skin may cause skin cancer. In 2018, the global Skin Cancer Diagnosis and Therapeutics market size was xx million …